Navigation Links
UCI-led study reveals how SARS virus hijacks host cells
Date:8/22/2013

Irvine, Calif., Aug. 22, 2013 UC Irvine infectious disease researchers have uncovered components of the SARS coronavirus which triggered a major outbreak of severe acute respiratory syndrome in 2002-03 that allow it to take over host cells in order to replicate.

This insight is critical for a full understanding of any outbreaks caused by such viruses and may prove beneficial in the development of therapies not only for human coronavirus infections but for other pathogenic illnesses as well. Study results appear online in the July/August issue of mBio.

Megan Angelini, a graduate student in Professor Michael Buchmeier's laboratory in the Department of Molecular Biology & Biochemistry at UC Irvine, and colleagues found that three proteins in the SARS coronavirus nsp3, nsp4 and nsp6 have the ability to hijack a host cell's internal membranes and utilize them to make more virus.

"Understanding how the virus uses the host cell to reproduce itself could lead to potential therapies for these kinds of pathogens," said Buchmeier, who is also deputy director of the Pacific Southwest Regional Center of Excellence for Biodefense & Emerging Infectious Diseases at UC Irvine.

Additionally, he said, since membrane rearrangement is a tactic employed by all known positive-sense, single-stranded RNA viruses, including those responsible for polio and dengue fever, this work adds to that body of knowledge.

Although the majority of infections caused by coronaviruses in humans are relatively mild, the SARS outbreak of 2002 and 2003 and the emergence last fall of the Middle East respiratory syndrome coronavirus highlight their ability to potentially infect millions around the globe.


'/>"/>

Contact: Andrea Burgess
andrea.burgess@uci.edu
949-824-6282
University of California - Irvine
Source:Eurekalert

Page: 1

Related biology news :

1. Circadian rhythms control bodys response to intestinal infections, UCI-led study finds
2. UCI-led study uncovers how Salmonella avoids the bodys immune response
3. Human brains are hardwired for empathy, friendship, study shows
4. 23andMe conducts the first genetic study of non-syndromic striae distensae (stretch marks)
5. Major study links aging gene to blood cancer
6. BIDMC cardiovascular institute researchers will lead $4 million NIH grant to study micrornas
7. ITN type 1 diabetes study identifies subset of patients with strong response to therapy
8. Rutgers study: Worms may shed light on human ability to handle chronic stress
9. Researchers study seleniums effects on horses
10. Latino families in study eat more fruits and veggies, drink less soda
11. Study finds novel worm community affecting methane release in ocean
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2016)... Rico , Jan. 15, 2016 Recent ... and small to find new ways to ensure data ... iOS and Android that ... on biometrics, transforming it into a hardware authorization token. ... users swipe their fingerprint on their KodeKey enabled device ...
(Date:1/11/2016)... Calif. , Jan. 11, 2016 Synaptics ... human interface solutions, today announced that its ClearPad ® ... integration (TDDI) products won two separate categories in the ... Mobile Innovator and Best Technology Breakthrough. The Synaptics ® ... cost, a simplified supply chain, thinner devices, brighter displays ...
(Date:1/8/2016)... 8, 2016 NXTD ), a ... ® , a privately held leading direct seller of ... 5000 fastest-growing company announced that on December 31, ... million in Nxt-ID to develop a proprietary new wireless ... ® , a unique smart wallet that serves to ...
Breaking Biology News(10 mins):
(Date:2/9/2016)... ... February 09, 2016 , ... ... innovations on its free and validated Electronic Data Capture (EDC) system ClinCaptureand its ... in Clinical Trials West Coast 2016 Conference in San Mateo, California on February ...
(Date:2/9/2016)... HOUSTON , Feb. 9, 2016 /PRNewswire/ ... virus-driven immunotherapies for cancer, announced that its ... the European Commission as an orphan medicinal ... the deadliest form of glioma, strikes approximately ... and EU. http://photos.prnewswire.com/prnh/20160208/330986LOGO ...
(Date:2/9/2016)... 9, 2016 DelveInsight,s, ... report provides in depth insights on the ... the Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors. The ... various stages of development including Discovery, Pre-clinical, ... and Preregistration. Report covers the product clinical ...
(Date:2/8/2016)... Inc. today announced that Director Robert A. Ingram has ... addition, Robert Keegan has been appointed to the Board ... --> North Carolina . --> ... $32.8 million of net proceeds in a private Mezzanine B financing ... Research Triangle area of North Carolina . ...
Breaking Biology Technology: